摘要
尿素中独特的分子内氢键让他们重要的官能团使药物靶点相互作用,从而在小分子中表现出广泛的生物活性。尿素在药物设计为分子选择性、稳定性、毒性和药物动力学行为方面的应用性相关的报道和大量优秀的成果使其成为了活跃的话题。这篇综述主要目的是提供洞察尿素在药物设计中的意义,通过总结各种衍生物作为调制器的生物目标的成功研究(即激酶,NAMPT,可溶性环氧化物水解酶,mTOR,蛋白酶,gyrB ,和表观遗传酶(如HDAC,PRMT或DOT1L等)。这篇评论的结果证实了尿素部分在药物化学的重要性,并刺激其使用的结构基序与合理的决策方法。
关键词: 尿素,药物设计,药物代谢动力学,酶抑制剂,表观动力学,分子间氢键。
Current Medicinal Chemistry
Title:Ureas: Applications in Drug Design
Volume: 24 Issue: 6
关键词: 尿素,药物设计,药物代谢动力学,酶抑制剂,表观动力学,分子间氢键。
摘要: The unique hydrogen binding capabilities of ureas make them an important functional group to make drug-target interactions and thus incorporated in small molecules displaying broad range of bioactivities. The related research and numerous excellent achievements of ureas applicability in drug design for the modulation of selectivity, stability, toxicity and pharmacokinetic profile of lead molecules have become active topic. This review aims to provide insights in to the significance of urea in drug design by summarizing successful studies of various urea derivatives as modulators biological targets (viz. kinases, NAMPT, soluble epoxide hydrolases, mTOR, proteases, gyrB/parE, and epigenetic enzymes (such as HDAC, PRMT or DOT1L etc.). The findings of this review confirm the importance of urea moiety in medicinal chemistry and stimulate its use as a structural motif with rational decision making approach.
Export Options
About this article
Cite this article as:
Ureas: Applications in Drug Design, Current Medicinal Chemistry 2017; 24 (6) . https://dx.doi.org/10.2174/0929867323666161129124915
DOI https://dx.doi.org/10.2174/0929867323666161129124915 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Preservation Solutions for Solid Organ Transplantation
Mini-Reviews in Medicinal Chemistry Therapeutically Targeting MicroRNAs in Liver Cancer
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers Sentinel Node in Endometrial Cancer: Rationale and Early Experience
Current Women`s Health Reviews Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression
Current Cancer Drug Targets Therapeutic Antibodies
Current Molecular Medicine Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma
Current Cancer Drug Targets Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis
Current Pharmaceutical Design Patented Biotechnological Applications of Serpin: an Update
Recent Patents on DNA & Gene Sequences Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Current Drug Targets Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Current Pharmaceutical Biotechnology Synthesis and Antiproliferative Evaluation of Hybrids of Indolin-2-one and Quinazoline-4(3H)-one Linked via Imine Bond
Letters in Drug Design & Discovery SDH Genes: From Glomic Tumours to Pheochromocytomas
Current Hypertension Reviews Role of Imaging in Testicular Cancer
Current Medical Imaging Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry